All lobbying filings

Forbes-Tate

Forbes-Tate filed a Q4 report for Invivyd on January 18, 2026.

Lobbying for Invivyd · Biopharmaceutical company

As filed: FORBES-TATE for INVIVYD.

All filings by Forbes-Tate · Everything Invivyd has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Connecticut

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Issues related to infectious diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem